55041-27-5

Basic information

• Product Name: 3,3-bis[4-hydroxy-3-methylphenyl]pentane
• Synonyms: 3,3-bis[4-hydroxy-3-methylphenyl]pentane
• CAS NO: 55041-27-5
• Molecular Weight: 284.398
• Mol File: 55041-27-5.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: 3,3-bis[4-hydroxy-3-methylphenyl]pentane(CAS DataBase Reference)
• NIST Chemistry Reference: 3,3-bis[4-hydroxy-3-methylphenyl]pentane(55041-27-5)
• EPA Substance Registry System: 3,3-bis[4-hydroxy-3-methylphenyl]pentane(55041-27-5)

Safety Data

• Hazardous Substances Data: 55041-27-5(Hazardous Substances Data)

Upstream product

• 95-48-7 ortho-cresol 
• 96-22-0 pentan-3-one 

Downstream Products

• 898253-48-0 4-(1-{4-[3-(2,6-dichloro-phenyl)-5-isopropyl-isoxazol-4-ylmethoxy]-3-methyl-phenyl}-1-ethyl-propyl)-2-methyl-phenol 
• 942194-55-0 4-[1-(4-amino-phenyl)-1-ethyl-propyl]-2-methyl-phenol 
• 917023-94-0 [5-(4-{1-ethyl-1-[4-(4-hydroxy-tetrahydropyran-4-ylethynyl)-3-methyl-phenyl]-propyl}-2-methyl-phenyl)-pyridin-3-yl]-acetic acid 
• 917022-98-1 2-(4-{1-ethyl-1-[3-methyl-4-(1-trimethylsilanyloxy-cyclohexylethynyl)-phenyl]-propyl}-2-methyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane 
• 917024-94-3 2-[4-(1-ethyl-1-{3-methyl-4-[2-(1-trimethylsilanyloxy-cyclohexyl)-ethyl]-phenyl}-propyl)-2-methyl-phenyl]-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane 
• 917026-30-3 4-(4-{1-ethyl-1-[3-methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-propyl}-2-methyl-phenylethynyl)-4-trimethylsilanyloxy-tetrahydropyran 
• 917026-46-1 2-(4-{1-ethyl-1-[3-methyl-4-(4-trimethylsilanyloxy-tetrahydro-thiopyran-4-ylethynyl)-phenyl]-propyl}-2-methyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane 
• 917023-90-6 (4'-{1-ethyl-1-[4-(1-hydroxy-cycloheptylethynyl)-3-methyl-phenyl]-propyl}-2'-methylbiphenyl-4-yl)-acetic acid 
• 917025-64-0 (4'-{1-ethyl-1-[4-(1-hydroxy-cyclopentylethynyl)-3-methyl-phenyl]-propyl}-3-fluoro-2'-methyl-biphenyl-4-yl)-acetic acid methyl ester 
• 917023-55-3 (4'-{1-ethyl-1-[4-(1-hydroxy-cyclopentylethynyl)-3-methyl-phenyl]-propyl}-3-fluoro-2'-methyl-biphenyl-4-yl)acetic acid 
• 917023-74-6 [4'-(1-ethyl-1-{4-[2-(1-hydroxy-cyclopentyl)-ethyl]-3-methyl-phenyl}-propyl)-3-fluoro-2'-methyl-biphenyl-4-yl]-acetic acid 
• 917023-09-7 (4'-{1-ethyl-1-[3-methyl-4-(4,4,4-trifluoro-3-hydroxy-3-trifluoromethyl-butyl)-phenyl]-propyl}-2'-methyl-biphenyl-4-yl)-acetic acid 
• 917023-08-6 (4'-{1-ethyl-1-[3-methyl-4-((E)-4,4,4-trifluoro-3-hydroxy-3-trifluoromethyl-1-butenyl)-phenyl]-propyl}-2'-methyl-biphenyl-4-yl)acetic acid 
• 917023-38-2 [2-(4-{1-ethyl-1-[3-methyl-4-((E)-4,4,4-trifluoro-3-hydroxy-3-trifluoromethyl-1-butenyl)-phenyl]-propyl}-2-methyl-phenyl)-thiazol-4-yl]-acetic acid 

Relevant articles and documents

Structure-activity relationships of bisphenol a analogs at estrogen receptors (ERs): Discovery of an ERα-selective antagonist

Our multi-template approach for drug discovery, focusing on protein targets with similar fold structures, has yielded lead compounds for various targets. We have also shown that a diphenylmethane skeleton can serve as a surrogate for a steroid skeleton. H

Vesicant treatment with phenyl-phenyl type vitamin d receptor modulators

The present invention relates to a method of treating or preventing damage to human skin cells by chemical vesicants by administering a non-secosteroidal, diphenyl compound with vitamin D receptor (VDR) modulating activity.

VITAMIN D RECEPTOR MODULATORS

The present invention relates to novel, non-secosteroidal, sulfonate and sulfonamide functional diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1α,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis. X-15439